Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination

References

• Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014;121:2081–2090
   PubMed Web of Science ®Google Scholar
• Casson RJ, Chidlow G, Wood JP, et al. Definition of glaucoma: clinical and experimental concepts. Clin Exp Ophthalmol 2012;40:341–349
   PubMed Web of Science ®Google Scholar
• Marquis RE, Whitson JT. Management of glaucoma: focus on pharmacological therapy. Drugs Aging 2005;22:1–21
   PubMed Web of Science ®Google Scholar
• Akyol N, Turk A, Cabuk Y, et al. Comparison of the effects of latanoprost 0.005% and carteolol 2% therapy in glaucoma. Glo-Kat 2006;1:119–122
   Google Scholar
• Khouri AS, Realini T, Fechtner RD. Use of fixed-dose combination drugs for the treatment of glaucoma. Drugs Aging 2007;24:1007–1016
   PubMed Web of Science ®Google Scholar
• Reardon G, Schwartz GF, Mozaffari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol 2004;137:S3–S12
   PubMed Web of Science ®Google Scholar
• Whitson JT. Glaucoma: a review of adjunctive therapy and new management strategies. Expert Opin Pharmacother 2007;8:3237–3249
   PubMed Web of Science ®Google Scholar
• Cohen JS, Gross RL, Cheetham JK, et al. Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension. Surv Ophthalmol 2004;49:S45–S52
   PubMed Web of Science ®Google Scholar
• Brandt JD, VanDenburgh AM, Chen K, Whitcup SM. Bimatoprost Study Group. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial. Ophthalmology 2001;108:1023–1031
   PubMed Web of Science ®Google Scholar
• Easthope SE, Perry CM. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension. Drugs Aging 2002;19:231–248
   PubMed Web of Science ®Google Scholar
• Cheng JW, Cheng SW, Gao LD, et al. Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis. PLoS One 2012;7:e45079
   PubMed Web of Science ®Google Scholar
• Turk A, Ceylan OM, Gokce G, et al. Comparison of brimonidine-timolol and dorzolamide-timolol in the management of intraocular pressure increase after phacoemulsification. Int J Ophthalmol 2015;8:945–949
   PubMed Web of Science ®Google Scholar
• Mundorf TK, Rauchman SH, Williams RD, Notivol R. Brinzolamide/Timolol Preference Study Group. A patient preference comparison of Azarga (brinzolamide/timolol fixed combination) vs Cosopt (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol 2008;2:623–628
   PubMedGoogle Scholar
• Lawthom C, Smith PE, Wild JM. Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity. Ophthalmology 2009;116:565–571
   PubMed Web of Science ®Google Scholar
• Adhi M, Duker JS. Optical coherence tomography-current and future applications. Curr Opin Ophthalmol 2013;24:213–221
   PubMed Web of Science ®Google Scholar
• Ucak H, Aykut V, Ozturk S, et al. Effect of oral isotretinoin treatment on retinal nerve fiber layer thickness. J Cutan Med Surg 2014;18:236–242
   PubMed Web of Science ®Google Scholar
• Turk A, Ceylan OM, Arici C, et al. Evaluation of the nerve fiber layer and macula in the eyes of healthy children using spectral-domain optical coherence tomography. Am J Ophthalmol 2012;153:552–559
   PubMed Web of Science ®Google Scholar
• Oishi A, Shimozono M, Mandai M, et al. Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2013;251:435–440
   PubMed Web of Science ®Google Scholar
• Turk A, Kola M, Akyol N, et al. Optical coherence tomography findings of active ocular toxoplasmosis complicating with serous macular detachment. Turkiye Klinikleri J Med Sci 2010;30:1409–1412
   Google Scholar
• Branchini LA, Adhi M, Regatieri CV, et al. Analysis of choroidal morphologic features and vasculature in healthy eyes using spectral-domain optical coherence tomography. Ophthalmology 2013;120:1901–1908
   PubMed Web of Science ®Google Scholar
• Kim YJ, Kang MH, Cho HY, et al. Comparative study of macular ganglion cell complex thickness measured by spectral-domain optical coherence tomography in healthy eyes, eyes with preperimetric glaucoma, and eyes with early glaucoma. Jpn J Ophthalmol 2014;58:244–251
   PubMed Web of Science ®Google Scholar
• Kola M, Kalkisim A, Karkucak M, et al. Evaluation of choroidal thickness in ankylosing spondylitis using optical coherence tomography. Ocul Immunol Inflamm 2014;22:434–438
   PubMed Web of Science ®Google Scholar
• Parentin F. Granulomatous anterior uveitis associated with bimatoprost: a case report. Ocul Immunol Inflamm 2003;11:67–71
   PubMed Web of Science ®Google Scholar
• Packer M, Fine IH, Hoffman RS. Bilateral nongranulomatous anterior uveitis associated with bimatoprost. J Cataract Refract Surg 2003;29:2242–2243
   PubMed Web of Science ®Google Scholar
• Kroll DM, Schuman JS. Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma. Am J Ophthalmol 2002;133:401–403
   PubMed Web of Science ®Google Scholar
• Krishnamurthy R, Senthil S, Garudadri CS. Late postoperative choroidal detachment following an uneventful cataract surgery in a patient on topical latanoprost. BMJ Case Rep 2015;2015. doi: 10.1136/bcr-2015-211408
   PubMedGoogle Scholar
• Cheggour M, Gambrelle J. Massive choroidal detachment secondary to topical use of bimatoprost: report of two cases. J Fr Ophtalmol 2012;35:176–180
   PubMed Web of Science ®Google Scholar
• Pathanapitoon K, Kunavisarut P. Choroidal detachment after topical prostaglandin analogs: case report. J Med Assoc Thai 2005;88:1134–1136
   PubMedGoogle Scholar
• Branchini L, Regatieri CV, Flores-Moreno I, et al. Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology 2012;119:119–123
   PubMed Web of Science ®Google Scholar
• Schmidt KG, von Rückmann A, Kemkes-Matthes B, Hammes HP. Ocular pulse amplitude in diabetes mellitus. Br J Ophthalmol 2000;84:1282–1284
   PubMed Web of Science ®Google Scholar
• Adhi M, Lau M, Liang MC, et al. Analysis of the thickness and vascular layers of the choroid in eyes with geographic atrophy using spectral-domain optical coherence tomography. Retina 2014;34:306–312
   PubMed Web of Science ®Google Scholar
• McCourt EA, Cadena BC, Barnett CJ, et al. Measurement of subfoveal choroidal thickness using spectral domain optical coherence tomography. Ophthalmic Surg Lasers Imaging 2010;41:S28–S33
   PubMedGoogle Scholar
• Maul EA, Friedman DS, Chang DS, et al. Choroidal thickness measured by spectral domain optical coherence tomography: factors affecting thickness in glaucoma patients. Ophthalmology 2011;118:1571–1579
   PubMed Web of Science ®Google Scholar
• Mwanza JC, Hochberg JT, Banitt MR, et al. Lack of association between glaucoma and macular choroidal thickness measured with enhanced depth-imaging optical coherence tomography. Invest Ophthalmol Vis Sci 2011;52:3430–3435
   PubMed Web of Science ®Google Scholar
• Jonas JB, Steinmetz P, Forster TM, et al. Choroidal thickness in open-angle glaucoma. J Glaucoma 2015;24:619–623
   PubMed Web of Science ®Google Scholar
• Reitsamer HA, Bogner B, Tockner B, Kiel JW. Effects of dorzolamide on choroidal blood flow, ciliary blood flow, and aqueous production in rabbits. Invest Ophthalmol Vis Sci 2009;50:2301–2307
   PubMed Web of Science ®Google Scholar
• Dallinger S, Bobr B, Findl O, et al. Effects of acetazolamide on choroidal blood flow. Stroke 1998;29:997–1001
   PubMed Web of Science ®Google Scholar
• Harris A, Jonescu-Cuypers CP. The impact of glaucoma medication on parameters of ocular perfusion. Curr Opin Ophthalmol 2001;12:131–137
   PubMed Web of Science ®Google Scholar
• Vetrugno M, Cardascia N, Cantatore F, Sborgia C. Comparison of the effects of bimatoprost and timolol on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: a prospective, open-label, randomized, two-arm, parallel-group study. Curr Ther Res Clin Exp 2004;65:444–454
   PubMed Web of Science ®Google Scholar
• Çalişkan S, Uğurbaş SC, Alpay A, Uğurbaş SH. Changes in the choroidal thickness and axial length upon mannitol infusion in patients with asymmetric intraocular pressure. J Glaucoma 2016;25:891–895
   PubMed Web of Science ®Google Scholar
• Lee AJ, McCluskey P. Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Ophthalmol 2010;4:741–764
   PubMedGoogle Scholar
• Kaback M, Scoper SV, Arzeno G, Brinzolamide 1%/Timolol 0.5% Study Group, et al. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%. Ophthalmology 2008;115:1728–1734
   PubMed Web of Science ®Google Scholar
• Caprioli J, Coleman AL. Blood Flow in Glaucoma Discussion. Blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol 2010;149:704–712
   PubMed Web of Science ®Google Scholar
• Punjabi OS, Ho HK, Kniestedt C, et al. Intraocular pressure and ocular pulse amplitude comparisons in different types of glaucoma using dynamic contour tonometry. Curr Eye Res 2006;31:851–862
   PubMed Web of Science ®Google Scholar